Dermatology
Advertisement
Dupilumab is a monoclonal antibody approved to treat atopic dermatitis in adolescents and children.
Omalizumab is a safe and effective long-term treatment for CSU.
Most respondents agreed a patient-centered definition would improve communication with providers.
Nearly 50% of patients with chronic spontaneous urticaria are atopic, with atopy linked to increased risk of dermatographism,
A recent study demonstrated significant associations between acute urticaria and cardiovascular comorbidities.
Autoimmune mast cell activation test shows promise as a diagnostic tool for chronic spontaneous urticaria.
The global prevalence of pediatric atopic dermatitis increased from 1990 to 2019.
Omalizumab treatment in CSU patients leads to significant changes in T-cell subpopulations.
Patients with both asthma and chronic urticaria have more severe allergic responses.
Omalizumab effectively reduces symptoms in CSU patients, but a 300 mg dose is recommended.
A systematic review found that biologic omalizumab is cost-effective for treating H1 antihistamine–refractory CSU.
survival odds are worse in people with darker skin tones.
Psoriasis was linked to greater odds of asthma and eczema.
According to a recent study, serum zonulin levels had a significant correlation with the urticaria activity score
veterans were more likely to be diagnosed with melanoma at an advanced stage
Eosinophil/neutrophil/platelet/basophil-to-lymphocyte ratios did not significantly change during 6 months of omalizumab.
Henry McMillan on engagement of Dermatologists, Allergists, and Advanced Practice Providers in new treatment trends training.
Autologous serum skin test status positivity, comorbid allergic diseases are associated with early response to omalizumab.
researchers mentioned that men 55 years and older had twice the incidence rate of melanoma compared with women the same age
Omalizumab updosing is commonly needed within the first 3 months of treatment for patients with severe CSU.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.